LIVER TRANSPLANTATION--THE ROLE OF DENDRITIC CELLS
肝移植——树突状细胞的作用
基本信息
- 批准号:2856784
- 负责人:
- 金额:$ 7.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-05-01 至 1999-04-30
- 项目状态:已结题
- 来源:
- 关键词:MHC class II antigen anergy antibody apoptosis cadherins cytokine cytokine receptors cytotoxic T lymphocyte dendritic cells extracellular matrix proteins gene expression heart transplantation homologous transplantation immune tolerance /unresponsiveness immunoglobulins immunosuppression integrins laboratory mouse liver transplantation phenotype polymerase chain reaction receptor binding selectins skin transplantation transplantation immunology
项目摘要
DESCRIPTION: (Adapted from the applicant's abstract) It is noted that the
orthotopic liver transplant model in mice results in virtually 100
percent tolerance and survival of recipients without need for
immunosuppression and also results in transfer of dendritic cells
systemically within the recipient. Progenitor dendritic cells are
deficient in MHC Class II and stimulatory molecule expression and
allostimulatory activity and can also prolong allograft survival in
certain circumstances. These immunosuppressive properties of progenitor
dendritic cells are controlled by both cytokines and by matrix
interactions. Therefore the applicant hypothesizes that regulation of the
expression of cell surface MHC antigens and T cell costimulatory
molecules on dendritic cells determines their potential to induce
tolerance and immunity. Three specific aims are proposed: I. Determine
how cytokines and matrix proteins alter the phenotype and function of
liver dendritic cells. II. Define the cellular and molecular mechanisms
by which alterations in dendritic cell phenotype and function alter T
cell responses in vitro. III. Establish the in vivo relevance of
alterations in dendritic cell expression of co-stimulatory molecules by
extending their observation that dendritic progenitors promote the
survival of organ allografts.
描述:(改编自申请人的摘要)请注意,
小鼠原位肝移植模型结果几乎为100例
不需要的接受者的耐受性和存活率
免疫抑制和树突状细胞的转移
在接受者内部有系统地。祖树突状细胞是
MHC II类和刺激性分子表达不足
同种异体刺激活性,并可延长同种异体移植物存活时间。
在某些情况下。祖细胞的这些免疫抑制特性
树突状细胞受细胞因子和基质的双重调控
互动。因此,申请人假设对
细胞表面MHC抗原的表达与T细胞共刺激
树突状细胞上的分子决定了它们诱导
宽容和豁免权。提出了三个具体目标:一、确定
细胞因子和基质蛋白如何改变细胞的表型和功能
肝脏树突状细胞。二、明确细胞和分子机制
树突状细胞表型和功能的改变通过改变T细胞
细胞在体外的反应。三、建立在体内的相关性
共刺激分子对树突状细胞表达的影响
扩大了他们的观察,树突状祖细胞促进
同种异体器官移植的存活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Angus W Thomson其他文献
Transplant Tolerance Induction: Insights From the Liver
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:
- 作者:
Helong Dai;Yawen Zheng;Angus W Thomson;Natasha M Rogers - 通讯作者:
Natasha M Rogers
Organ transplantation—how much of the promise has been realized?
器官移植——兑现了多少承诺?
- DOI:
10.1038/nm1251 - 发表时间:
2005-06-03 - 期刊:
- 影响因子:50.000
- 作者:
Robert I Lechler;Megan Sykes;Angus W Thomson;Laurence A Turka - 通讯作者:
Laurence A Turka
Angus W Thomson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Angus W Thomson', 18)}}的其他基金
Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients
活体肾移植受者的调节性树突状细胞治疗
- 批准号:
9924470 - 财政年份:2018
- 资助金额:
$ 7.41万 - 项目类别:
Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients
活体肾移植受者的调节性树突状细胞治疗
- 批准号:
10153679 - 财政年份:2018
- 资助金额:
$ 7.41万 - 项目类别:
Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients
活体肾移植受者的调节性树突状细胞治疗
- 批准号:
10396484 - 财政年份:2018
- 资助金额:
$ 7.41万 - 项目类别:
Regulatory immune cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
NHP肾移植中的调节性免疫细胞治疗、耐受性促进及潜在机制
- 批准号:
10518430 - 财政年份:2017
- 资助金额:
$ 7.41万 - 项目类别:
Regulation of Liver DC Function and Transplant Tolerance
肝脏 DC 功能和移植耐受的调节
- 批准号:
9927591 - 财政年份:2017
- 资助金额:
$ 7.41万 - 项目类别:
Regulatory immune cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
NHP肾移植中的调节性免疫细胞治疗、耐受性促进及潜在机制
- 批准号:
9329522 - 财政年份:2017
- 资助金额:
$ 7.41万 - 项目类别:
Regulatory immune cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
NHP肾移植中的调节性免疫细胞治疗、耐受性促进及潜在机制
- 批准号:
10217982 - 财政年份:2017
- 资助金额:
$ 7.41万 - 项目类别:
Regulatory dendritic cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
NHP 肾移植中的调节性树突状细胞治疗、耐受性促进及潜在机制
- 批准号:
10596904 - 财政年份:2017
- 资助金额:
$ 7.41万 - 项目类别:
相似海外基金
The Influence of TCR afinity for self-peptide on the quality and stability of CD8+ cell anergy
TCR对自身肽的亲和力对CD8细胞无反应性质量和稳定性的影响
- 批准号:
473889 - 财政年份:2022
- 资助金额:
$ 7.41万 - 项目类别:
Miscellaneous Programs
Understand mechanisms of mast cell reactivity and induced anergy and how these are modulated by biologics in food allergy treatment
了解肥大细胞反应性和诱导无反应性的机制,以及在食物过敏治疗中生物制剂如何调节这些机制
- 批准号:
2456902 - 财政年份:2020
- 资助金额:
$ 7.41万 - 项目类别:
Studentship
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10178141 - 财政年份:2020
- 资助金额:
$ 7.41万 - 项目类别:
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10055413 - 财政年份:2020
- 资助金额:
$ 7.41万 - 项目类别:
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10431828 - 财政年份:2020
- 资助金额:
$ 7.41万 - 项目类别:
The Role of Cell Surface Receptor Spatial Organization in Maintaining B Cell Anergy
细胞表面受体空间组织在维持 B 细胞无能性中的作用
- 批准号:
553837-2020 - 财政年份:2020
- 资助金额:
$ 7.41万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10647749 - 财政年份:2020
- 资助金额:
$ 7.41万 - 项目类别:
The role of Runx1 in the regulation of T cell anergy
Runx1在T细胞无反应性调节中的作用
- 批准号:
10311471 - 财政年份:2020
- 资助金额:
$ 7.41万 - 项目类别:
B cell anergy, modified LDL uptake, and atherosclerosis
B 细胞无反应性、修饰的 LDL 摄取和动脉粥样硬化
- 批准号:
9886286 - 财政年份:2018
- 资助金额:
$ 7.41万 - 项目类别: